nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-6A3ED447·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.1 Basic medicine·Subfield: Molecular Biology·Basis: Full text·Type: Laboratory experiment

Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

Freya Lyssy et al.Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger et al.·2023·Reproductive BioMedicine Online·10.1016/j.rbmo.2023.04.006 ↗

Primary claim

S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

Tentative · small BeWo mRNA experiment without a reported direct comparison against the thrombin-only control
In brief

Placental receptor mapping documents gestational expression differences, but the platelet-specific interpretation remains limited by an unresolved thrombin contribution.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

RESEARCH QUESTION: Sphingosine-1-phosphate (S1P) is an essential and bioactive sphingolipid with various functions, which acts through five different G-protein-coupled receptors (S1PR1-5). What is the localization of S1PR1-S1PR3 in the human placenta and what is the effect of different flow rates, various oxygen concentrations and platelet-derived factors on the expression profile of S1PR in trophoblasts? DESIGN: Expression dynamics of placental S1PR1-S1PR3 were determined in human first trimester (n = 10), pre-term (n = 9) and term (n = 10) cases. Furthermore, the study investigated the expression of these receptors in different primary cell types isolated from human placenta, verified the findings with publicly available single-cell RNA-Seq data from first trimester and immunostaining of human first trimester and term placentas. The study also tested whether the placental S1PR subtypes are dysregulated in differentiated BeWo cells under different flow rates, different oxygen concentrations or in the presence of platelet-derived factors. RESULTS: Quantitative polymerase chain reaction revealed that S1PR2 is the predominant placental S1PR in the first trimester and reduces towards term (P < 0.0001). S1PR1 and S1PR3 increased from first trimester towards term (P < 0.0001). S1PR1 was localized in endothelial cells, whereas S1PR2 and S1PR3 were predominantly found in villous trophoblasts. Furthermore, S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055). CONCLUSION: This study suggests that the placental S1PR repertoire is differentially expressed across gestation. S1PR2 expression in villous trophoblasts is negatively influenced by platelet-derived factors, which could contribute to down-regulation of placental S1PR2 over time of gestation as platelet presence and activation in the intervillous space increases from the middle of the first trimester onwards.

Key Claims

Primary finding · Tentative

S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

small BeWo mRNA experiment without a reported direct comparison against the thrombin-only control

Abstract, Results; Results, Figure 4H
Quote verified
Secondary · Supported

Quantitative polymerase chain reaction revealed that S1PR2 is the predominant placental S1PR in the first trimester and reduces towards term (P < 0.0001). S1PR1 and S1PR3 increased from first trimester towards term (P < 0.0001).

cross-sectional bulk-tissue comparisons support gestational differences but cannot separate changing cell composition from receptor regulation

Abstract, Results; Results, Figure 1A–F
Quote verified
Secondary · Supported

S1PR1 was localized in endothelial cells, whereas S1PR2 and S1PR3 were predominantly found in villous trophoblasts.

complementary localization assays support cell-type differences, although S1PR3 predominance remains unresolved across modalities and gestational sampling

Abstract, Results; Results, Figures 2 and 3
Quote verified
Secondary · Tentative

qPCR analysis showed no influence on the expression level of S1PR2 and S1PR3 in response to flow rates of 1 ml/min and 3 ml/min, respectively

four BeWo experiments without quantified shear stress or biological positive-control validation provide limited evidence for an absent flow response

Results, 'S1PR2 and S1PR3 are dysregulated by platelet-derived factors'
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Gestational profiling establishes a descriptive reference

Placental samples from first trimester, pre-term, and term pregnancies document contrasting S1PR1–3 expression patterns. This provides a focused reference for investigating gestational receptor regulation.

↳ Table 1; Figure 1

#methodological rigour

Platelet barrier addresses RNA contamination directly

The insert separates platelets from BeWo cells, and CD42b staining and electron microscopy verify the barrier arrangement. This addresses contamination of the trophoblast readout by platelet receptor RNA.

↳ Methods, platelet co-incubation; Figure 4E–G

#positioning

Relevant literature connects receptors and placentation

The Introduction and Discussion relate receptor expression to trophoblast differentiation, migration, vascular signaling, and maternal platelet entry. The Discussion also explicitly acknowledges the direct thrombin effect.

↳ Introduction; Discussion

Limitations

#methodological rigour

Platelet attribution and replication remain unresolved

Thrombin alone changes S1PR2 (P = 0.0461), while activated-platelet exposure differs from untreated control (P = 0.0055), without a reported direct comparison between those treatments. The three platelet experiments and primary-cell assays also lack a complete account of donor and passage independence.

↳ Methods, platelet co-incubation; Figures 3–4

#reporting

Headline wording extends beyond the tested model

The Abstract Conclusion attributes the response to villous trophoblasts, but the exposure experiment measures mRNA in differentiated BeWo cells. Primary-trophoblast and protein-level confirmation are not provided for this intervention.

↳ Abstract, Conclusion; Figure 4H

#reporting

Localization and cohort descriptions require qualification

The Abstract's predominantly trophoblast localization of S1PR3 is not reconciled with the single-cell Results emphasizing fibroblasts and decidual stroma. The Results also describes tissue donors as healthy although most pre-term deliveries had clinical indications specified in Methods.

↳ Abstract, Results; Results, cell-type localization; Methods, Human placental tissue samples

Does this match your read? Add your assessment ↓

Nabu Commentary

Figures 1–3 combine gestational tissue comparisons with complementary localization approaches, establishing a descriptive contribution rather than a resolved regulatory mechanism. The insert verification in Figure 4 addresses platelet RNA contamination, but the significant thrombin-only response and missing direct treatment contrast prevent clean attribution to platelet cargo. Small in vitro experiments and incompletely specified donor/passage replication further limit experimental inference. The Abstract extends the BeWo response to villous trophoblasts, while the Discussion gives insufficient attention to cell-line extrapolation and clinical differences in the pre-term cohort.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.1±0.2

Contribution
3.4

The gestational expression profile and cell-localization evidence provide a focused descriptive extension of existing placental S1P research. The platelet experiment adds a preliminary model-system observation rather than an established explanation of placental regulation.

Results, Figures 1–4; Discussion
Methodological Rigour
2.9

Tissue assays, primary cells, single-cell data, and a verified platelet barrier provide complementary evidence. Platelet attribution remains uncertain because thrombin also changes S1PR2, while small experiments and incompletely specified donor/passage replication limit precision and independence assessment.

Methods, platelet co-incubation and primary-cell isolation; Figures 3–4
Reporting
3.3

The manuscript follows a clear sequence from gestational expression to localization and experimental exposures. Its headline conclusion nevertheless generalizes the BeWo-cell result to villous trophoblasts, despite more cautious mechanistic wording elsewhere.

Abstract, Conclusion; Results, Figure 4; Discussion
Positioning
3.3

The Introduction and Discussion connect the findings to placental S1P signaling, trophoblast behavior, and platelet biology, and acknowledge thrombin effects and the exclusion of S1PR4/5. Interpretation does not sufficiently incorporate the BeWo-model constraints or the clinical indications underlying most pre-term samples.

Introduction; Discussion; Methods, Human placental tissue samples

Reliability

Caveats4 of 4 checks


Results checkNoted
  • S1PR1 was localized in endothelial cells, whereas S1PR2 and S1PR3 were predominantly found in villous trophoblasts: "S1PR1 was localized in endothelial cells, whereas S1PR2 and S1PR3 were predominantly found in villous trophoblasts" (Abstract, Results) vs "S1PR3 was detected mainly in placental fibroblasts, decidual stroma cells and to some extent in villous cytotrophoblasts and decidual natural killer cells" (Results, S1PR are differentially expressed across different placental cell types). Comparison of the Abstract and single-cell Results leaves S1PR3 predominance unresolved, although immunostaining supports trophoblast localization and the single-cell data cover only first trimester. → Effect on result unclear
Reporting and transparencyNoted

Ethics approval, consent, conflicts, and on-request data availability are declared. A Results citation points to a nonexistent Figure 2 panel.

Conflict of interest: declared · Ethics approval: declared · Data availability: declared

Reference IntegrityClean

49 references in manuscript 48 of 49 checkable references found in an index 1 mistyped DOI matched to the cited work by its details

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceEmpirical
Route to useNot stated
AdvanceExtends
CitationsFWCI 0.4
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The down-regulation of S1PR2 by platelet-derived factors was pinned down under controlled in-vitro conditions in a differentiated BeWo trophoblast cell line, not in patients or primary tissue function.

The discussion only calls for further research on S1PR patterns and placental development, naming no real-world use of these findings.

Pathway

Reproductive biologists and obstetric researchers would build on this mechanism to study platelet-driven S1PR dysregulation in pregnancy complications such as pre-eclampsia.

Barrier

The finding rests on a BeWo cell-line co-culture model, with no confirmation in primary trophoblasts or in-vivo placenta, and the mechanism remains undetermined.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

    Nadja Kupper, Berthold Huppertz · 2021 · Basic medicine

    Primary claim

    in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats
  2. Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy

    Bandres-Meriz, Kunz, Havelund, et al. · 2023 · Clinical medicine

    Primary claim

    palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

    Supported
    Evidence Score
    2.6±0.2
    Reliability
    Concerns
  3. Tig1 regulates proximo-distal identity during salamander limb regeneration

    Oliveira, Knapp, Elewa, et al. · 2022 · Biological sciences

    Primary claim

    Tig1 reprogrammes distal cells to a proximal identity, upregulating Prod1 and inhibiting Hoxa13 and distal transcriptional networks

    Tentative
    Evidence Score
    3.8±0.1
    Reliability
    Caveats

How the rubric works →